In the wake of the bounty program New Orleans Saints face troubled waters with the DEA


Oct, 9, 2011; Charlotte, NC, USA; New Orleans Saints helmets on the field before the game at Bank of America Stadium. Mandatory Credit: Bob Donnan-US PRESSWIRE

Despite their “troubled” loss to the Washington Redskins on Sunday, the New Orleans Saints face another bump in the road. This time it stands with a DEA investigation that began several years ago. has disclosed information regarding the Saints receiving fines and penalties in connection with a prescription painkiller lawsuit originally pursued in 2010. The Saints were first denounced with the mishandling of their stock of prescription drugs and team officials are blamed for hiding the declared theft of Vicodin from team supply.

The DEA is more upset with “lack of organizational control and oversight” rather then those players associated. The investigation would eventually lead to a civil settlement which would include fines that break close to over six figures. The DEA claims to have “strong evidence” against the Saints to further hand out severe penalties.

When questioned about the incident from two years ago, Saints officials had this to say,

"“This is an ongoing, highly confidential case. We have no comment.”"